Trials / Completed
CompletedNCT00250237
Post-operative Haloperidol Versus Placebo for Prevention of Post-operative Delirium After Acute Hip Surgery
Randomised Double-blind Placebo-controlled Study of Post-operative Haloperidol Versus Placebo for Prevention of Post-operative Delirium After Acute Hip Surgery
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 220 (actual)
- Sponsor
- Bronovo Hospital · Academic / Other
- Sex
- All
- Age
- 75 Years
- Healthy volunteers
- Accepted
Summary
In this study the investigators want to determine if treatment with haloperidol direct post-operatively after acute hip surgery in high risk patients protects against developing a post-operative delirium.
Detailed description
A post-operative delirium is a serious and frequent (35-65%) complication with high morbidity and mortality in high risk patients. In this study we investigate whether we can prevent a delirium from occuring after surgery in patients with a hip fracture of 75 years of age and older. It's a randomised double-blind single centre placebo-controlled study of haloperidol versus placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Haloperidol | Haloperidol 1mg twice daily during 72hours |
| DRUG | placebo | Placebo 1mg twice daily during 72hours |
Timeline
- Start date
- 2005-11-01
- Primary completion
- 2008-11-01
- Completion
- 2009-02-01
- First posted
- 2005-11-08
- Last updated
- 2009-08-07
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT00250237. Inclusion in this directory is not an endorsement.